Edwards Lifesciences (EW) News Today $74.94 -0.17 (-0.23%) Closing price 03:59 PM EasternExtended Trading$76.44 +1.50 (+1.99%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Edwards Lifesciences to Present at the BofA Securities 2025 Health Care Conference | EW Stock NewsMay 6 at 12:06 PM | gurufocus.comEdwards Lifesciences to Present at the BofA Securities 2025 Health Care ConferenceMay 6 at 12:05 PM | gurufocus.comBrown Advisory Inc. Boosts Stock Holdings in Edwards Lifesciences Co. (NYSE:EW)Brown Advisory Inc. lifted its holdings in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 7.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,155,355 shares of the medical research coMay 6 at 7:31 AM | marketbeat.comEdwards Lifesciences Q1 Earnings TranscriptMay 6 at 7:17 AM | marketbeat.comEdwards Lifesciences to Present at the BofA Securities 2025 Health Care ConferenceMay 6 at 7:05 AM | businesswire.com74,154 Shares in Edwards Lifesciences Co. (NYSE:EW) Bought by Banque Transatlantique SABanque Transatlantique SA acquired a new stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 74,154 shares of the medical research company's stock, valued at approxMay 6 at 6:50 AM | marketbeat.comBellevue Group AG Lowers Position in Edwards Lifesciences Co. (NYSE:EW)Bellevue Group AG trimmed its position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 3.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,097,848 shares of the medical reMay 6 at 6:32 AM | marketbeat.comAlyeska Investment Group L.P. Invests $49.04 Million in Edwards Lifesciences Co. (NYSE:EW)Alyeska Investment Group L.P. acquired a new stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 662,405 shares of the medical research company's stock, valued at approximately $49,038,000.May 6 at 5:30 AM | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Sold by Axa S.A.Axa S.A. cut its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 10.8% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 691,962 shares of the medical research company's stock after selling 83,539 shares during the period. Axa S.A. ownedMay 6 at 5:14 AM | marketbeat.comMercer Global Advisors Inc. ADV Buys Shares of 121,385 Edwards Lifesciences Co. (NYSE:EW)Mercer Global Advisors Inc. ADV purchased a new position in Edwards Lifesciences Co. (NYSE:EW - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 121,385 shares of the medical research compaMay 6 at 5:04 AM | marketbeat.comComerica Bank Trims Stock Holdings in Edwards Lifesciences Co. (NYSE:EW)Comerica Bank lowered its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 7.1% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 126,262 shares of the medical research company's stock after selling 9,687 sharesMay 6 at 4:55 AM | marketbeat.comAdvanced Portfolio Management LLC Invests $328,000 in Edwards Lifesciences Co. (NYSE:EW)Advanced Portfolio Management LLC acquired a new position in Edwards Lifesciences Co. (NYSE:EW - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The fund acquired 4,532 shares of the medical research company's stock, valued at approximately $328,000. A numberMay 5 at 6:14 AM | marketbeat.comBalanced Outlook on Edwards Lifesciences: Navigating FDA Approval and Capacity ConstraintsMay 5 at 5:30 AM | tipranks.com1248 Management LLC Makes New $1.22 Million Investment in Edwards Lifesciences Co. (NYSE:EW)1248 Management LLC bought a new stake in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 16,498 shares of the medical research company's stock, valued at apMay 4 at 7:44 AM | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Sees Significant Drop in Short InterestEdwards Lifesciences Co. (NYSE:EW - Get Free Report) was the recipient of a significant decline in short interest during the month of April. As of April 15th, there was short interest totalling 7,930,000 shares, a decline of 16.9% from the March 31st total of 9,540,000 shares. Based on an average daily volume of 4,830,000 shares, the short-interest ratio is presently 1.6 days. Approximately 1.4% of the shares of the stock are short sold.May 4 at 7:27 AM | marketbeat.comLido Advisors LLC Sells 459,416 Shares of Edwards Lifesciences Co. (NYSE:EW)Lido Advisors LLC trimmed its holdings in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 95.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 19,642 shares of the medical research company's stock after sellMay 4 at 5:05 AM | marketbeat.comFreestone Grove Partners LP Purchases New Shares in Edwards Lifesciences Co. (NYSE:EW)Freestone Grove Partners LP purchased a new position in Edwards Lifesciences Co. (NYSE:EW - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 761,214 shares of the medical research coMay 3 at 6:45 AM | marketbeat.comEdwards Lifesciences (NYSE:EW) Hits New 52-Week Low - Time to Sell?Edwards Lifesciences (NYSE:EW) Hits New 12-Month Low - What's Next?May 3 at 6:18 AM | marketbeat.comSchonfeld Strategic Advisors LLC Buys 70,201 Shares of Edwards Lifesciences Co. (NYSE:EW)Schonfeld Strategic Advisors LLC boosted its stake in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 137.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 121,386 shares of the medicMay 3 at 5:53 AM | marketbeat.comNorthern Trust Corp Raises Stock Position in Edwards Lifesciences Co. (NYSE:EW)Northern Trust Corp grew its holdings in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 21.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,505,227 shares of the medical research company's sMay 2, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Sold by The Manufacturers Life Insurance CompanyThe Manufacturers Life Insurance Company decreased its position in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 31.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,284,949 shares of the medical research compMay 2, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Sold by Soros Fund Management LLCSoros Fund Management LLC cut its holdings in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 16.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 250,000 shares of the mMay 1, 2025 | marketbeat.comKovitz Investment Group Partners LLC Has $3.06 Million Holdings in Edwards Lifesciences Co. (NYSE:EW)Kovitz Investment Group Partners LLC raised its position in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 79.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 41,337 shares of the medical research company's stock after buying an additional 18,2April 30, 2025 | marketbeat.comQuarry LP Has $518,000 Stock Holdings in Edwards Lifesciences Co. (NYSE:EW)Quarry LP boosted its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 117.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 6,997 shares of the medical research company's stoApril 29, 2025 | marketbeat.comFirst Trust Advisors LP Grows Stake in Edwards Lifesciences Co. (NYSE:EW)First Trust Advisors LP increased its position in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 66.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 270,611 shares of the medical research company's stock after acquApril 29, 2025 | marketbeat.comLeerink Partnrs Issues Pessimistic Outlook for EW EarningsEdwards Lifesciences Co. (NYSE:EW - Free Report) - Analysts at Leerink Partnrs cut their Q4 2025 EPS estimates for Edwards Lifesciences in a research report issued on Thursday, April 24th. Leerink Partnrs analyst M. Kratky now anticipates that the medical research company will post earnings of $0April 29, 2025 | marketbeat.comSusquehanna Fundamental Investments LLC Takes Position in Edwards Lifesciences Co. (NYSE:EW)Susquehanna Fundamental Investments LLC acquired a new position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 458,527 shares of the medical research company'sApril 28, 2025 | marketbeat.comHancock Whitney Corp Sells 10,362 Shares of Edwards Lifesciences Co. (NYSE:EW)Hancock Whitney Corp reduced its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 33.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 20,379 shares of the medical research company's stock after selling 10,362 shares duringApril 28, 2025 | marketbeat.comSyon Capital LLC Buys New Shares in Edwards Lifesciences Co. (NYSE:EW)Syon Capital LLC purchased a new position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 4,807 shares of the medical research company's stock, valued at approximately $356,000. A numApril 28, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Stock Holdings Decreased by Price T Rowe Associates Inc. MDPrice T Rowe Associates Inc. MD decreased its position in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 6.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 3,297,722 shares of the medical research company's stock after selling 244,061 shares duringApril 28, 2025 | marketbeat.comStifel Financial Corp Has $16.57 Million Stock Position in Edwards Lifesciences Co. (NYSE:EW)Stifel Financial Corp lessened its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 3.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 223,857 shares of the medical researchApril 28, 2025 | marketbeat.comLeerink Partnrs Has Bearish Forecast for EW Q4 EarningsApril 28, 2025 | americanbankingnews.comEdwards Lifesciences (NYSE:EW) Given New $75.00 Price Target at Canaccord Genuity GroupApril 28, 2025 | americanbankingnews.comCanaccord Genuity Group Issues Positive Forecast for Edwards Lifesciences (NYSE:EW) Stock PriceCanaccord Genuity Group increased their price objective on Edwards Lifesciences from $71.00 to $75.00 and gave the stock a "hold" rating in a research note on Friday.April 27, 2025 | marketbeat.comResearch Analysts Offer Predictions for EW Q2 EarningsEdwards Lifesciences Co. (NYSE:EW - Free Report) - Equities research analysts at William Blair increased their Q2 2026 earnings per share (EPS) estimates for Edwards Lifesciences in a research report issued to clients and investors on Thursday, April 24th. William Blair analyst M. Andrew now foreApril 27, 2025 | marketbeat.comFY2025 Earnings Estimate for EW Issued By Leerink PartnrsEdwards Lifesciences Co. (NYSE:EW - Free Report) - Equities researchers at Leerink Partnrs lifted their FY2025 EPS estimates for shares of Edwards Lifesciences in a research note issued on Thursday, April 24th. Leerink Partnrs analyst M. Kratky now forecasts that the medical research company willApril 27, 2025 | marketbeat.comVoya Investment Management LLC Cuts Stock Holdings in Edwards Lifesciences Co. (NYSE:EW)Voya Investment Management LLC cut its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 30.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,335,938 shares of the medical research company's stocApril 27, 2025 | marketbeat.comBanco Bilbao Vizcaya Argentaria S.A. Increases Stake in Edwards Lifesciences Co. (NYSE:EW)Banco Bilbao Vizcaya Argentaria S.A. grew its position in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 13.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 149,596 shares of the mApril 27, 2025 | marketbeat.comDark Forest Capital Management LP Buys 7,196 Shares of Edwards Lifesciences Co. (NYSE:EW)Dark Forest Capital Management LP increased its position in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 224.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 10,404 shares of theApril 27, 2025 | marketbeat.comLeerink Partnrs Issues Optimistic Estimate for EW EarningsApril 27, 2025 | americanbankingnews.comEdwards Lifesciences (NYSE:EW) Price Target Raised to $75.00April 27, 2025 | americanbankingnews.comEdwards Lifesciences (NYSE:EW) Upgraded at Piper SandlerApril 27, 2025 | americanbankingnews.comAdage Capital Partners GP L.L.C. Acquires 389,141 Shares of Edwards Lifesciences Co. (NYSE:EW)Adage Capital Partners GP L.L.C. boosted its stake in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 46.6% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,223,893 shares of the medical research company's stocApril 26, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Sold by Kayne Anderson Rudnick Investment Management LLCKayne Anderson Rudnick Investment Management LLC lessened its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 98.4% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 1,025 shares of the medical research company's stock after selling 62,335 shares duriApril 26, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Position Trimmed by State of Tennessee Department of TreasuryState of Tennessee Department of Treasury lowered its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 3.5% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 270,225 shares of the medical research company's stock after sApril 25, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Position Increased by Dimensional Fund Advisors LPDimensional Fund Advisors LP boosted its holdings in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 27.9% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 2,995,208 shares of the medical research company's stock after buying an additioApril 25, 2025 | marketbeat.comHold Rating on Edwards Lifesciences: Balancing Positive Trends with TAVR UncertaintiesApril 25, 2025 | tipranks.comEdwards Lifesciences price target raised to $75 from $72 at BairdApril 25, 2025 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Edwards Lifesciences (EW), Resmed (RMD) and Thermo Fisher (TMO)April 24, 2025 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Walgreens Boots Alliance (WBA) and Merus (MRUS)April 24, 2025 | markets.businessinsider.com Get Edwards Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EW and its competitors with MarketBeat's FREE daily newsletter. Email Address EW Media Mentions By Week EW Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EW News Sentiment▼1.200.69▲Average Medical News Sentiment EW News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EW Articles This Week▼2524▲EW Articles Average Week Get Edwards Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EW and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Boston Scientific News Stryker News Medtronic News Becton, Dickinson and Company News IDEXX Laboratories News ResMed News DexCom News STERIS News Insulet News Baxter International News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:EW) was last updated on 5/6/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump Orders 'National Digital Asset Stockpile'Trump's tariffs on China have caused a ripple effect across global markets. But in crypto? They've lit a fu...Crypto 101 Media | SponsoredREVEALED: Elon’s Secret Master Plan “AGENDA X”REVEALED: Elon's Secret Master Plan "AGENDA X" For almost 30 years, Elon worked on his master plan in secre...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edwards Lifesciences Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Edwards Lifesciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.